About the Event

Registrations are now open for MTPConnect’s SA Insights Series for February.

Stephanie Morris, Director of Innovation & Translation, Adelaide Intermediary Program will be joined by CEO of BioCina, Ian Wisenberg, and Vice President and General Manager Michael Tsaconas for a fire-side chat.

During this chat you will learn about the history of this iconic manufacturing site and SA’s Contract Development Manufacturing Organisation (CDMO) capability.

Discover what can be produced, market reach, and lessons learnt in scaling the business model.

Ian will share insights into the importance of relationship building and the opportunities and challenges of being part of a global organisation.

Ian’s philosophy “never do tomorrow what you can do today,” has fueled his entrepreneurial successes – Let’s discover what Ian and BioCina have planned for tomorrow and beyond.

This event will be followed by an opportunity to network over drinks and nibbles.

Who should attend:

Researchers, C-suite professionals in the Health and Medical Innovation sector, investors, and entrepreneurs, clinicians, Medtech Pharma, BioTech and Digital health industry professionals, commercialisation executives, and members of the Adelaide ecosystem.

Bring a Plus 1

Meet, greet, and take a seat at the SA Insights Series. Register for TWO today, meet-up at the SA Insights Series event and you are in the running to WIN a prize.

Bring a colleague or invite a person you have been trying to connect with.

We look forward to seeing you both at the event.

** please provide the name and email details for your guest during the registration process, so we can confirm numbers for catering**

Behind the scene of a cGMP Manufacturing Facility

The team at BioCina are offering 10 guests the chance to go behind the scenes and take a look at SA's one-of-a-kind CDMO facility.

On this guided tour you will see the clean rooms for our upstream, downstream, solution preparation and plasmid DNA suites.Our BioCina host will talk you through each of the key manufacturing processes and unit operation steps.

Conditions of entry

• Closed toe shoes and socks must be worn

• No makeup or jewellery (including watches, wedding bands, earrings etc.) is to be worn into the facility and must be removed prior to entry.

• Plant uniforms, shoe covers, hair nets, beard covers, and safety glasses will be provided to visitors. Compliance to gowning requirements is mandatory for entry.

Limited to 10 guests: Book Now

Ian Wisenberg bio:

Ian Wisenberg’s career spans over three decades in international business with an emphasis in finance, capital formation, corporate and business development. Ian has been an integral leader charting innovation and growth across several Bridgewest Group biotech companies. As CEO for BioCina, he leads a highly accomplished team, recognized for its strong history as a multi-product biologics contract development and manufacturing organization (CDMO).

Prior to taking the helm at BioCina, Ian was founder and Chief Business Officer of BioArdis, a preclinical biopharmaceutical development company of the Bridgewest Group. He transitioned to this new role from Chief Financial Officer at BioDuro after the Bridgewest Group sale to Advent International in 2019.

Previously, Ian ran a very successful consulting practice, BioGlobal Consulting Group, which had an extensive client list of biotech and pharma companies in the USA and abroad. Ian is from Cape Town, South Africa, and attended the University of Cape Town.

About BioCina:

BioCina is a CDMO with the only FDA-approved microbial drug substance facility of its kind in Australia, providing high-quality, cost-effective process development and manufacturing solutions to biopharmas worldwide.

The site, based in Thebarton, was approved by the FDA for commercial manufacturing in 2020.

In 2020, BoCina was acquired by The Bridgewest Group, a closely held investment company with global assets in biotech, wireless communications, infrastructure for “internet of things”, semiconductor, real estate, and financial services. In business for over 25 years, Bridgewest has operations across the USA, Europe, Australia and Asia.

With customised services, BioCina has successfully performed multiple technology transfers, and developed unique solutions to address technical issues for customers’ programs. BioCina strives to provide high quality, cost effective microbial process development and manufacturing solutions to customers worldwide.

More information: BioCina

In the know:

Do you want to know more about the Adelaide Intermediary Program? Click the link and watch a presentation by Adelaide Intermediary Program Director Jo Close.

Stay connected to events, news and opportunities - Follow MTPConnect on EventBrite, click the follow button in the top right corner of the event listing.

Parking:

Parking is available onsite at the BioCina facility. On-street parking is also available.

Further Information:

For more information, please contact Engagement and Communications Manager Pia Vogrin on Pia.Vogrin@mtpconnect.org.au or 0419 853 614.

---